US Stock MarketDetailed Quotes

CADL Candel Therapeutics

Watchlist
  • 4.660
  • +0.040+0.87%
Trading Nov 27 09:56 ET
151.34MMarket Cap-2693P/E (TTM)

Candel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0.00%125K
0.00%31K
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
0.00%125K
0.00%31K
Cost of revenue
Gross profit
Operating expense
-1.04%8.76M
-10.41%8.57M
-17.87%7.9M
10.32%38.39M
28.08%10.35M
-0.71%8.85M
8.91%9.57M
6.70%9.62M
40.46%34.8M
6.06%8.08M
Selling and administrative expenses
10.78%3.34M
-1.45%3.59M
-8.74%3.8M
-1.24%13.89M
-3.16%3.06M
-14.71%3.02M
-3.11%3.65M
15.67%4.16M
31.73%14.06M
-19.33%3.16M
-General and administrative expense
10.78%3.34M
-1.45%3.59M
-8.74%3.8M
-1.24%13.89M
-3.16%3.06M
-14.71%3.02M
-3.11%3.65M
15.67%4.16M
31.73%14.06M
-19.33%3.16M
Research and development costs
-7.34%5.42M
-16.09%4.98M
-25.00%4.1M
17.89%24.51M
45.98%7.26M
8.72%5.85M
18.16%5.93M
0.96%5.47M
36.95%20.79M
29.01%4.97M
Other operating expenses
----
----
----
----
----
---12K
---12K
---12K
95.54%-48K
----
Operating profit
1.04%-8.76M
10.41%-8.57M
17.87%-7.9M
-10.72%-38.39M
-28.57%-10.35M
0.36%-8.85M
-9.30%-9.57M
-7.07%-9.62M
-40.67%-34.67M
-6.09%-8.05M
Net non-operating interest income expense
-50.30%-251K
-71.20%-327K
-419.61%-326K
-4.90%-514K
-214.16%-258K
5.11%-167K
47.67%-191K
158.29%102K
-824.53%-490K
2,154.55%226K
Non-operating interest income
-52.99%236K
-47.02%240K
-54.99%320K
70.85%2.08M
-48.38%415K
46.36%502K
547.14%453K
--711K
--1.22M
--804K
Non-operating interest expense
-27.20%487K
-11.96%567K
6.08%646K
51.93%2.6M
16.44%673K
28.90%669K
48.05%644K
--609K
--1.71M
--578K
Other net income (expense)
-381.93%-1.64M
-9,363.19%-13.34M
-99.03%7K
-94.10%966K
-117.60%-483K
57.45%581K
-97.10%144K
-91.26%724K
243.33%16.37M
-70.17%2.74M
Gain on sale of security
-381.93%-1.64M
-9,363.19%-13.34M
-99.03%7K
-94.10%966K
-117.60%-483K
57.45%581K
-97.10%144K
-91.26%724K
243.33%16.37M
-70.17%2.74M
Income before tax
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
Income tax
Net income
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
Net income continuous Operations
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
Minority interest income
Net income attributable to the parent company
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-101.87%-37.94M
-118.28%-11.1M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.8M
47.97%-18.79M
-418.48%-5.08M
Basic earnings per share
-13.79%-0.33
-124.24%-0.74
6.67%-0.28
-101.54%-1.31
-111.11%-0.38
3.33%-0.29
-135.71%-0.33
-900.00%-0.3
65.97%-0.65
-423.57%-0.18
Diluted earnings per share
-13.79%-0.33
-124.24%-0.74
6.67%-0.28
-101.54%-1.31
-111.11%-0.38
3.33%-0.29
-135.71%-0.33
-900.00%-0.3
65.97%-0.65
-423.57%-0.18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000000000.00%125K0.00%31K
Operating revenue --0--0--0--0--0--0--0--00.00%125K0.00%31K
Cost of revenue
Gross profit
Operating expense -1.04%8.76M-10.41%8.57M-17.87%7.9M10.32%38.39M28.08%10.35M-0.71%8.85M8.91%9.57M6.70%9.62M40.46%34.8M6.06%8.08M
Selling and administrative expenses 10.78%3.34M-1.45%3.59M-8.74%3.8M-1.24%13.89M-3.16%3.06M-14.71%3.02M-3.11%3.65M15.67%4.16M31.73%14.06M-19.33%3.16M
-General and administrative expense 10.78%3.34M-1.45%3.59M-8.74%3.8M-1.24%13.89M-3.16%3.06M-14.71%3.02M-3.11%3.65M15.67%4.16M31.73%14.06M-19.33%3.16M
Research and development costs -7.34%5.42M-16.09%4.98M-25.00%4.1M17.89%24.51M45.98%7.26M8.72%5.85M18.16%5.93M0.96%5.47M36.95%20.79M29.01%4.97M
Other operating expenses -----------------------12K---12K---12K95.54%-48K----
Operating profit 1.04%-8.76M10.41%-8.57M17.87%-7.9M-10.72%-38.39M-28.57%-10.35M0.36%-8.85M-9.30%-9.57M-7.07%-9.62M-40.67%-34.67M-6.09%-8.05M
Net non-operating interest income expense -50.30%-251K-71.20%-327K-419.61%-326K-4.90%-514K-214.16%-258K5.11%-167K47.67%-191K158.29%102K-824.53%-490K2,154.55%226K
Non-operating interest income -52.99%236K-47.02%240K-54.99%320K70.85%2.08M-48.38%415K46.36%502K547.14%453K--711K--1.22M--804K
Non-operating interest expense -27.20%487K-11.96%567K6.08%646K51.93%2.6M16.44%673K28.90%669K48.05%644K--609K--1.71M--578K
Other net income (expense) -381.93%-1.64M-9,363.19%-13.34M-99.03%7K-94.10%966K-117.60%-483K57.45%581K-97.10%144K-91.26%724K243.33%16.37M-70.17%2.74M
Gain on sale of security -381.93%-1.64M-9,363.19%-13.34M-99.03%7K-94.10%966K-117.60%-483K57.45%581K-97.10%144K-91.26%724K243.33%16.37M-70.17%2.74M
Income before tax -26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M
Income tax
Net income -26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M
Net income continuous Operations -26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M
Minority interest income
Net income attributable to the parent company -26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -26.21%-10.65M-131.30%-22.24M6.53%-8.22M-101.87%-37.94M-118.28%-11.1M2.91%-8.44M-131.72%-9.61M-906.29%-8.8M47.97%-18.79M-418.48%-5.08M
Basic earnings per share -13.79%-0.33-124.24%-0.746.67%-0.28-101.54%-1.31-111.11%-0.383.33%-0.29-135.71%-0.33-900.00%-0.365.97%-0.65-423.57%-0.18
Diluted earnings per share -13.79%-0.33-124.24%-0.746.67%-0.28-101.54%-1.31-111.11%-0.383.33%-0.29-135.71%-0.33-900.00%-0.365.97%-0.65-423.57%-0.18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data